BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu Q, Chu H, Ma Y, Wu T, Qian F, Ren X, Tu W, Zhou X, Jin L, Wu W, Wang J. Salvianolic Acid B Attenuates Experimental Pulmonary Fibrosis through Inhibition of the TGF-β Signaling Pathway. Sci Rep 2016;6:27610. [PMID: 27278104 DOI: 10.1038/srep27610] [Cited by in Crossref: 34] [Cited by in F6Publishing: 45] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Yang Z, Qi J, Ping D, Sun X, Tao Y, Liu C, Peng Y. Salvia miltiorrhiza in thorax and abdomainal organ fibrosis: A review of its pharmacology. Front Pharmacol 2022;13:999604. [DOI: 10.3389/fphar.2022.999604] [Reference Citation Analysis]
2 Liu J, Sun Q, Sun X, Wang Q, Zou G, Wang D, Zhuang B, Juan Z, Zhang R, Zhang D. Therapeutic Effects of Salvianolic Acid B on Angiotensin II-Induced Atrial Fibrosis by Regulating Atrium Metabolism via Targeting AMPK/FoxO1/miR-148a-3p Axis. J Cardiovasc Transl Res 2022. [PMID: 35984595 DOI: 10.1007/s12265-022-10303-3] [Reference Citation Analysis]
3 Murthy P, Shaibie NA, Lim CL, Ling APK, Chye SM, Koh RY. An Overview of Herbal Medicines for Idiopathic Pulmonary Fibrosis. Processes 2022;10:1131. [DOI: 10.3390/pr10061131] [Reference Citation Analysis]
4 Liu Y, Cheng L, Zhan H, Li H, Li X, Huang Y, Li Y. The Roles of Noncoding RNAs in Systemic Sclerosis. Front Immunol 2022;13:856036. [DOI: 10.3389/fimmu.2022.856036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yeqing C, Xinsheng F, Liping Z, Fangyuan H, Pengli W. Screening and evaluation of quality markers from Shuangshen Pingfei formula for idiopathic pulmonary fibrosis using network pharmacology and pharmacodynamic, phytochemical, and pharmacokinetic analyses. Phytomedicine 2022;100:154040. [PMID: 35334302 DOI: 10.1016/j.phymed.2022.154040] [Reference Citation Analysis]
6 Hasan M, Paul NC, Paul SK, Saikat ASM, Akter H, Mandal M, Lee SS. Natural Product-Based Potential Therapeutic Interventions of Pulmonary Fibrosis. Molecules 2022;27:1481. [PMID: 35268581 DOI: 10.3390/molecules27051481] [Reference Citation Analysis]
7 Ding L, Li Y, Yang Y, Song S, Qi H, Wang J, Wang Z, Zhao J, Zhang W, Zhao L, Zhao D, Li X, Wang Z. Wenfei Buqi Tongluo Formula Against Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β/Smad3 Pathway. Front Pharmacol 2021;12:762998. [PMID: 35126110 DOI: 10.3389/fphar.2021.762998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wang Y, Sang X, Shao R, Qin H, Chen X, Xue Z, Li L, Wang Y, Zhu Y, Chang Y, Gao X, Zhang B, Zhang H, Yang J. Xuanfei Baidu Decoction protects against macrophages induced inflammation and pulmonary fibrosis via inhibiting IL-6/STAT3 signaling pathway. J Ethnopharmacol 2022;283:114701. [PMID: 34606948 DOI: 10.1016/j.jep.2021.114701] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Estornut C, Milara J, Bayarri MA, Belhadj N, Cortijo J. Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis. Front Pharmacol 2022;12:794997. [DOI: 10.3389/fphar.2021.794997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Griffin MF, Borrelli MR, Garcia JT, Januszyk M, King M, Lerbs T, Cui L, Moore AL, Shen AH, Mascharak S, Diaz Deleon NM, Adem S, Taylor WL, desJardins-Park HE, Gastou M, Patel RA, Duoto BA, Sokol J, Wei Y, Foster D, Chen K, Wan DC, Gurtner GC, Lorenz HP, Chang HY, Wernig G, Longaker MT. JUN promotes hypertrophic skin scarring via CD36 in preclinical in vitro and in vivo models. Sci Transl Med 2021;13:eabb3312. [PMID: 34516825 DOI: 10.1126/scitranslmed.abb3312] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
11 Szwedowicz U, Szewczyk A, Gołąb K, Choromańska A. Evaluation of Wound Healing Activity of Salvianolic Acid B on In Vitro Experimental Model. Int J Mol Sci 2021;22:7728. [PMID: 34299351 DOI: 10.3390/ijms22147728] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Wang L, Li S, Yao Y, Yin W, Ye T. The role of natural products in the prevention and treatment of pulmonary fibrosis: a review. Food Funct 2021;12:990-1007. [PMID: 33459740 DOI: 10.1039/d0fo03001e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
13 Luo X, Deng Q, Xue Y, Zhang T, Wu Z, Peng H, Xuan L, Pan G. Anti-Fibrosis Effects of Magnesium Lithospermate B in Experimental Pulmonary Fibrosis: By Inhibiting TGF-βRI/Smad Signaling. Molecules 2021;26:1715. [PMID: 33808650 DOI: 10.3390/molecules26061715] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Zhang Y, Lu P, Qin H, Zhang Y, Sun X, Song X, Liu J, Peng H, Liu Y, Nwafor EO, Li J, Liu Z. Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: Rationale and therapeutic potential. Biomed Pharmacother 2021;133:111072. [PMID: 33378971 DOI: 10.1016/j.biopha.2020.111072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
15 Yang A, Huang Y, Zhang Y, Yang K, Wang J, Liu Q. [Expression of pituitary tumor-transforming gene-1 and its pathogenic role in systemic sclerosis]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:1564-70. [PMID: 33243736 DOI: 10.12122/j.issn.1673-4254.2020.11.05] [Reference Citation Analysis]
16 Xing X, Qiang W, Bao J, Yang R, Hou J, Tao K, Meng Z, Zhang J, Zhang A, Sun X. Jinbei Oral Liquid ameliorates bleomycin-induced idiopathic pulmonary fibrosis in rats via reversion of Th1/Th2 shift. Chinese Herbal Medicines 2020;12:273-80. [DOI: 10.1016/j.chmed.2020.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Mei X, Zhao H, Huang Y, Tang Y, Shi X, Pu W, Jiang S, Ma Y, Zhang Y, Bai L, Tu W, Zhao Y, Jin L, Wu W, Wang J, Liu Q. Involvement of Disabled-2 on skin fibrosis in systemic sclerosis. J Dermatol Sci 2020;99:44-52. [PMID: 32571632 DOI: 10.1016/j.jdermsci.2020.05.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Yin ZF, Wei YL, Wang X, Wang LN, Li X. Buyang Huanwu Tang inhibits cellular epithelial-to-mesenchymal transition by inhibiting TGF-β1 activation of PI3K/Akt signaling pathway in pulmonary fibrosis model in vitro. BMC Complement Med Ther 2020;20:13. [PMID: 32020862 DOI: 10.1186/s12906-019-2807-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
19 Heo SY, Jeong MS, Lee HS, Kim YJ, Park SH, Jung WK. Phlorofucofuroeckol A from Ecklonia cava ameliorates TGF-β1-induced fibrotic response of human tracheal fibroblasts via the downregulation of MAPKs and SMAD 2/3 pathways inactivated TGF-β receptor. Biochem Biophys Res Commun 2020;522:626-32. [PMID: 31785808 DOI: 10.1016/j.bbrc.2019.11.127] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
20 Liu G, Zhai H, Zhang T, Li S, Li N, Chen J, Gu M, Qin Z, Liu X. New therapeutic strategies for IPF: Based on the "phagocytosis-secretion-immunization" network regulation mechanism of pulmonary macrophages. Biomed Pharmacother 2019;118:109230. [PMID: 31351434 DOI: 10.1016/j.biopha.2019.109230] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
21 Xie B, Zhu W, Ding P, Chen M, Li J, Lei L, Zhang C, Nie H. Nanofiber scaffolds attenuate collagen synthesis of human dermal fibroblasts through TGF- β 1/TSG-6 pathway. J Phys Mater 2019;2:044001. [DOI: 10.1088/2515-7639/ab2563] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zhang Y, Lu W, Zhang X, Lu J, Xu S, Chen S, Zhong Z, Zhou T, Wang Q, Chen J, Liu P. Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways. Pharmacol Res 2019;147:104307. [PMID: 31181334 DOI: 10.1016/j.phrs.2019.104307] [Cited by in Crossref: 18] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
23 Ma L, Tang L, Yi Q. Salvianolic Acids: Potential Source of Natural Drugs for the Treatment of Fibrosis Disease and Cancer. Front Pharmacol 2019;10:97. [PMID: 30842735 DOI: 10.3389/fphar.2019.00097] [Cited by in Crossref: 33] [Cited by in F6Publishing: 41] [Article Influence: 11.0] [Reference Citation Analysis]
24 Qiu Y, Pan X, Hu Y. Polydatin ameliorates pulmonary fibrosis by suppressing inflammation and the epithelial mesenchymal transition via inhibiting the TGF-β/Smad signaling pathway. RSC Adv 2019;9:8104-12. [DOI: 10.1039/c8ra08659a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Liu Q, Lu J, Lin J, Tang Y, Pu W, Shi X, Jiang S, Liu J, Ma Y, Li Y, Xu J, Jin L, Wang J, Wu W. Salvianolic acid B attenuates experimental skin fibrosis of systemic sclerosis. Biomed Pharmacother 2019;110:546-53. [PMID: 30530290 DOI: 10.1016/j.biopha.2018.12.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
26 Zhang K, Ma Z, Wang W, Liu R, Zhang Y, Yuan M, Li G. Effect of doxycycline on chronic intermittent hypoxia-induced atrial remodeling in rats. Herz 2020;45:668-75. [DOI: 10.1007/s00059-018-4768-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Hosseini S, Imenshahidi M, Hosseinzadeh H, Karimi G. Effects of plant extracts and bioactive compounds on attenuation of bleomycin-induced pulmonary fibrosis. Biomedicine & Pharmacotherapy 2018;107:1454-65. [DOI: 10.1016/j.biopha.2018.08.111] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
28 Wang C, Luo H, Xu Y, Tao L, Chang C, Shen X. Salvianolic Acid B-Alleviated Angiotensin II Induces Cardiac Fibrosis by Suppressing NF-κB Pathway In Vitro. Med Sci Monit 2018;24:7654-64. [PMID: 30365482 DOI: 10.12659/MSM.908936] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
29 Qiu H, Liu W, Lan T, Pan W, Chen X, Wu H, Xu D. Salvianolate reduces atrial fibrillation through suppressing atrial interstitial fibrosis by inhibiting TGF-β1/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in post-MI rats. Phytomedicine 2018;51:255-65. [PMID: 30466624 DOI: 10.1016/j.phymed.2018.09.238] [Cited by in Crossref: 32] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
30 Dhapare S, Sakagami M. Salvianolic acid B as an anti-emphysema agent I: In vitro stimulation of lung cell proliferation and migration, and protection against lung cell death, and in vivo lung STAT3 activation and VEGF elevation. Pulm Pharmacol Ther 2018;53:107-15. [PMID: 30291890 DOI: 10.1016/j.pupt.2018.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
31 Liu Q, Shi X, Tang L, Xu W, Jiang S, Ding W, Feng Q, Chu H, Ma Y, Li Y, Lu J, Pu W, Zhou X, Jin L, Wang J, Wu W. Salvianolic acid B attenuates experimental pulmonary inflammation by protecting endothelial cells against oxidative stress injury. Eur J Pharmacol 2018;840:9-19. [PMID: 30273543 DOI: 10.1016/j.ejphar.2018.09.030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
32 Shi X, Liu Q, Li N, Tu W, Luo R, Mei X, Ma Y, Xu W, Chu H, Jiang S, Du Z, Zhao H, Zhao L, Jin L, Wu W, Wang J. MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor. Cell Cycle 2018;17:1967-78. [PMID: 30145936 DOI: 10.1080/15384101.2018.1509621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
33 Dhapare S, Li H, Sakagami M. Salvianolic acid B as an anti-emphysema agent II: In vivo reversal activities in two rat models of emphysema. Pulm Pharmacol Ther 2018;53:52-60. [PMID: 30193865 DOI: 10.1016/j.pupt.2018.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
34 Li J, Zhang C, He W, Qiao H, Chen J, Wang K, Oupický D, Sun M. Coordination-driven assembly of catechol-modified chitosan for the kidney-specific delivery of salvianolic acid B to treat renal fibrosis. Biomater Sci 2017;6:179-88. [PMID: 29170782 DOI: 10.1039/c7bm00811b] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
35 Park B, Hong SC, Park SW, Yi C, Ha Y, Choi D. Herbal medicine for hemorrhage-related hydrocephalus: A systematic review of randomised controlled trials. Complementary Therapies in Medicine 2018;39:146-53. [DOI: 10.1016/j.ctim.2018.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
36 Wang J, Zhai W, Yu J, Wang J, Dai J. Preparation and Quality Evaluation of Salvianolic Acids and Tanshinones Dry Powder Inhalation. J Pharm Sci 2018;107:2451-6. [PMID: 29883664 DOI: 10.1016/j.xphs.2018.05.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
37 Luong VH, Chino T, Oyama N, Matsushita T, Sasaki Y, Ogura D, Niwa SI, Biswas T, Hamasaki A, Fujita M, Okamoto Y, Otsuka M, Ihn H, Hasegawa M. Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis. Arthritis Res Ther 2018;20:46. [PMID: 29544542 DOI: 10.1186/s13075-018-1534-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
38 Chu H, Jiang S, Liu Q, Ma Y, Zhu X, Liang M, Shi X, Ding W, Zhou X, Zou H, Qian F, Shaul PW, Jin L, Wang J. Sirtuin1 Protects against Systemic Sclerosis-related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes. Am J Respir Cell Mol Biol 2018;58:28-39. [PMID: 28800254 DOI: 10.1165/rcmb.2016-0192OC] [Cited by in Crossref: 30] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
39 Guan Y, Zhu JP, Shen J, Jia YL, Jin YC, Dong XW, Xie QM. Salvianolic acid B improves airway hyperresponsiveness by inhibiting MUC5AC overproduction associated with Erk1/2/P38 signaling. Eur J Pharmacol 2018;824:30-9. [PMID: 29382534 DOI: 10.1016/j.ejphar.2018.01.050] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
40 Li M, Li Y, Li J, Zhao P, Bai Y, Feng S, Liu X, Wang Y, Bian Q, Li J. Long-Term Effects of TCM Yangqing Kangxian Formula on Bleomycin-Induced Pulmonary Fibrosis in Rats via Regulating Nuclear Factor-κB Signaling. Evid Based Complement Alternat Med 2017;2017:2089027. [PMID: 29387126 DOI: 10.1155/2017/2089027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
41 Yang L, Lin Z, Wang Y, Li C, Xu W, Li Q, Yao W, Song Z, Liu G. Nickle(II) ions exacerbate bleomycin-induced pulmonary inflammation and fibrosis by activating the ROS/Akt signaling pathway. Environ Sci Pollut Res 2018;25:4406-18. [DOI: 10.1007/s11356-017-0525-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
42 Li X, Zhu L, Wang B, Yuan M, Zhu R. Drugs and Targets in Fibrosis. Front Pharmacol 2017;8:855. [PMID: 29218009 DOI: 10.3389/fphar.2017.00855] [Cited by in Crossref: 39] [Cited by in F6Publishing: 47] [Article Influence: 7.8] [Reference Citation Analysis]
43 Li H, Hao Y, Zhang H, Ying W, Li D, Ge Y, Ying B, Cheng B, Lian Q, Jin S. Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice. Sci Rep 2017;7:46754. [PMID: 28466866 DOI: 10.1038/srep46754] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
44 Chen F, Wang C, Sun J, Wang J, Wang L, Li J. Salvianolic acid B reduced the formation of epidural fibrosis in an experimental rat model. J Orthop Surg Res 2016;11:141. [PMID: 27852325 DOI: 10.1186/s13018-016-0475-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
45 Yu CC, Yu CH, Chang YC. Aberrant SSEA-4 upregulation mediates myofibroblast activity to promote pre-cancerous oral submucous fibrosis. Sci Rep 2016;6:37004. [PMID: 27845370 DOI: 10.1038/srep37004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]